These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19796969)

  • 1. Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study.
    Ybarra J; Pou JM; Romeo JH; Merce J; Jurado J
    J Diabetes Complications; 2010; 24(5):306-12. PubMed ID: 19796969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients.
    Nybo M; Poulsen MK; Grauslund J; Henriksen JE; Rasmussen LM
    Diabet Med; 2010 Mar; 27(3):289-94. PubMed ID: 20536491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of transforming growth factor beta 1 in south Indian type 2 diabetic subjects.
    Viswanathan V; Snehalatha C; Nair MB; Kumutha R; Ramachandran A
    Diabetes Metab Res Rev; 2005; 21(3):276-80. PubMed ID: 15586391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
    Happich M; Breitscheidel L; Meisinger C; Ulbig M; Falkenstein P; Benter U; Watkins J
    Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of TGF-β1 in patients of diabetic peripheral neuropathy and its correlation with nerve conduction velocity in type 2 diabetes mellitus.
    Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S135-9. PubMed ID: 26559756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor and expression of its receptors in patients with diabetic neuropathy.
    Kim HC; Cho YJ; Ahn CW; Park KS; Kim JC; Nam JS; Im YS; Lee JE; Lee SC; Lee HK
    Diabet Med; 2009 Dec; 26(12):1228-34. PubMed ID: 20002474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino-terminal brain natriuretic peptide is related to the presence of diabetic polyneuropathy independently of cardiovascular disease.
    Jurado J; Ybarra J; Ferrandiz M; Comerma L; Pou JM
    Diabetes Care; 2007 Aug; 30(8):e86. PubMed ID: 17855271
    [No Abstract]   [Full Text] [Related]  

  • 10. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.
    Chen HS; Wu TE; Jap TS; Lu RA; Wang ML; Chen RL; Lin HD
    Diabet Med; 2007 Dec; 24(12):1336-44. PubMed ID: 17941864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.
    Van Acker K; Bouhassira D; De Bacquer D; Weiss S; Matthys K; Raemen H; Mathieu C; Colin IM
    Diabetes Metab; 2009 Jun; 35(3):206-13. PubMed ID: 19297223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients?
    Spallone V; Maiello MR; Kurukulasuriya N; Barini A; Lovecchio M; Tartaglione R; Mennuni G; Menzinger G
    Diabet Med; 2004 Nov; 21(11):1174-80. PubMed ID: 15498082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark study.
    Hansen CS; Jensen TM; Jensen JS; Nawroth P; Fleming T; Witte DR; Lauritzen T; Sandbaek A; Charles M; Fleischer J; Vistisen D; Jørgensen ME
    Diabet Med; 2015 Jun; 32(6):778-85. PubMed ID: 25761542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of soluble Fas in serum from diabetic patients with neuropathy.
    Guillot R; Bringuier AF; Porokhov B; Guillausseau PJ; Feldmann G
    Diabetes Metab; 2001 Jun; 27(3):315-21. PubMed ID: 11431596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.
    Lu B; Yang Z; Wang M; Yang Z; Gong W; Yang Y; Wen J; Zhang Z; Zhao N; Zhu X; Hu R
    Diabetes Res Clin Pract; 2010 Jun; 88(3):289-94. PubMed ID: 20359765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics.
    Bilal N; Erdogan M; Ozbek M; Cetinkalp S; Karadeniz M; Ozgen AG; Saygili F; Yilmaz C; Tüzün M; Kabalak T
    J Diabetes Complications; 2008; 22(3):181-5. PubMed ID: 18413163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy.
    Chen H; Zheng Z; Li R; Lu J; Bao Y; Ying X; Zeng R; Jia W
    Am J Nephrol; 2010; 32(1):47-56. PubMed ID: 20523035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes.
    Cabré A; Lázaro I; Girona J; Manzanares J; Marimón F; Plana N; Heras M; Masana L
    J Intern Med; 2007 Oct; 262(4):496-503. PubMed ID: 17875187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.